In Uncategorized Posted
TBVAC-HORIZON kicks off
The Horizon Europe programme has funded the TBVAC-HORIZON project to improve the understanding of lung immunity to tuberculosis infection and to establish a diversified innovative TB vaccine [...]
The Horizon Europe programme has funded the TBVAC-HORIZON project to improve the understanding of lung immunity to tuberculosis infection and to establish a diversified innovative TB vaccine [...]
The four EDCTP-funded late-stage TB vaccine development projects: POR TB Consortium, priMe and MTBVAC-Newborns Phase 2a and MTBVACN3, meet on a regular basis to exchange knowledge and [...]
TB remains one of the leading causes of death from an infectious agent. In 2021 – 10.6 million people fell sick with TB; 1.6 million people died. New vaccines that are effective against all forms [...]
The Institut Pasteur IN-PERSON TB course will be held in Paris on the Pasteur campus June 5 – 16, 2023. The flyer describes the course program, and more information is available on the website: [...]
In Silico Trials methodologies will play a growing and fundamental role in the development and de-risking of new medical devices in the future. While the regulatory pathway for Digital Patient [...]
Runderweg 6
8219 PK Lelystad
The Netherlands
Email: info@tbvi.eu
Phone: +31 320 277 550